Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPSE | Q9Y251 | 6/20 | 0.31 |
| ▸ | FGF1 | P05230 | 3/20 | 0.31 |
| ▸ | FGF2 | P09038 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18914843 | 0.88 | SELP (0.35) | HPSEFGF1FGF2 | |
| SCHEMBL17167842 | 0.87 | MDK (0.41) | HPSEFGF1FGF2 | |
| SCHEMBL17167763 | 0.83 | SELP (0.33) | — | |
| SCHEMBL17167538 | 0.83 | — | — | |
| SCHEMBL18915133 | 0.83 | MDK (0.39) | HPSEFGF1FGF2 | |
| SCHEMBL17167540 | 0.80 | TLR4 (0.35) | HPSEFGF1FGF2 | |
| SCHEMBL18914918 | 0.75 | MDK (0.40) | HPSEFGF1FGF2 | |
| SCHEMBL17167729 | 0.73 | F10 (0.40) | HPSEFGF1FGF2 | |
| SCHEMBL17167546 | 0.73 | F10 (0.45) | HPSEFGF1FGF2 | |
| SCHEMBL18914846 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150291644-A1 | Saccharide Dendritic Cluster Compounds as Inhibitors of Bace-1 | VICTORIA LINK LTD (NZ) | 2015-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291644-A1 | Saccharide Dendritic Cluster Compounds as Inhibitors of Bace-1 | BACE1, BACE2, APP | HPSE 134/4885FGF1 1768/4885FGF2 2224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.